No pain, no strain: Targin® mitigates pain and constipation following spinal cord injury

Ann Clin Transl Neurol. 2023 Mar;10(3):453-458. doi: 10.1002/acn3.51734. Epub 2023 Jan 24.

Abstract

Background: Opioids effectively reduce chronic pain, but present significant side effects including opioid-induced constipation. Oxycodone/naloxone decreases pain and constipation in cancer patients, however its effect on spinal cord injury population remains understudied.

Methods: We assessed whether oxycodone/naloxone reduces pain, constipation, and severity of autonomic dysreflexia in an individual with spinal cord injury. A 55-year-old male with C5 lesion presented with chief complaint of chronic pain received 5/2.5 mg and 20/10 mg oxycodone/naloxone for 6 and 2 weeks, respectively.

Results: Oxycodone/naloxone improved pain, bowel function, and autonomic dysreflexia severity.

Interpretation: Oxycodone/naloxone was effective in managing chronic pain and constipation in the studied case.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Analgesics, Opioid / adverse effects
  • Autonomic Dysreflexia* / chemically induced
  • Autonomic Dysreflexia* / drug therapy
  • Chronic Pain*
  • Constipation / chemically induced
  • Constipation / etiology
  • Delayed-Action Preparations / adverse effects
  • Drug Combinations
  • Humans
  • Male
  • Middle Aged
  • Naloxone / adverse effects
  • Narcotic Antagonists / adverse effects
  • Oxycodone / adverse effects
  • Spinal Cord Injuries* / complications

Substances

  • Analgesics, Opioid
  • Oxycodone
  • Drug Combinations
  • Delayed-Action Preparations
  • Narcotic Antagonists
  • Naloxone